We collected information about Pharmasset Inc Hours for you. Follow the liks to find out everything about Pharmasset Inc Hours.
https://www.yellowpages.com/princeton-nj/mip/pharmasset-inc-6356753
Pharmasset Inc. (609) 613-4100. 303 College Rd E Princeton, NJ 08540. Map & Directions. Consultants Referral Service. Be the first to review! Add Hours. 9. YEARS.
https://www.yelp.com/biz/pharmasset-durham
Location & Hours. 2520 Meridian Pkwy. Ste 110. Durham, NC 27713. Get directions. Edit business info. ... You could be the first review for Pharmasset. 0 reviews that are not currently recommended. Phone number (919) 287-4250. Get Directions. 2520 Meridian Pkwy Ste …
https://www.sec.gov/Archives/edgar/data/882095/000119312511331318/d260880dex991.htm
Pharmasset, Inc. We have audited the accompanying balance sheets of Pharmasset, Inc. (the “Company”) as of September 30, 2011 and 2010, and the related statements of operations and comprehensive net loss, stockholders’ equity, and cash flows for each of the three years in the period ended September 30, 2011. These financial statements are ...
https://www.crunchbase.com/organization/pharmasset
Pharmasset Inc is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Their primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus, or HBV, hepatitis C virus, or HCV and human immunodeficiency virus, or HIV. ...
https://www.sec.gov/Archives/edgar/data/1301081/000119312509092086/dex991.htm
A live webcast and slide presentation will be available through the Investor Relations pages of both InterMune and Pharmasset at www.intermune.com or www.pharmasset.com, respectively. Alternatively, interested parties may access the discussion and ask questions by dialing 888-799-0528 (U.S. and Canada) or 973-200-3372 (international ...
https://www.gilead.com/news-and-press/press-room/press-releases/2011/11/gilead-sciences-to-acquire-pharmasset-inc-for-11-billion
Gilead Sciences, Inc. (Nasdaq:GILD) and Pharmasset, Inc. (Nasdaq:VRUS) announced today that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash. The transaction, which values Pharmasset at approximately $11 billion, was unanimously approved by Pharmasset's Board of Directors.
https://www.marketscreener.com/quote/stock/PHARMASSET-INC-49756/
PHARMASSET, INC. : Gilead Sciences clôture le rachat de Pharmasset, Inc. 2012. PHARMASSET, INC. : Gilead Sciences complète son offre publique d'achat de toutes les actio.. 2011. PHARMASSET, INC. : Gilead Sciences va racheter Pharmasset, Inc. pour 11 milliards de dolla..
https://en.wikipedia.org/wiki/Pharmasset
Pharmasset Inc. was a pharmaceutical company based in Princeton, New Jersey in the United States. The company develops antiviral drugs for HIV (including racivir), hepatitis B (including clevudine, marketed as Levovir), and hepatitis C. In November 2011, Pharmasset was acquired by …
https://www.marketwatch.com/story/gilead-to-acquire-pharmasset-for-nearly-11bln-2011-11-21
Gilead Sciences Inc. GILD, +1.33% agreed to acquire Pharmasset Inc. VRUS, -15.63% for nearly $11 billion, placing a big bet on the growing market for new treatments for hepatitis C infections.
https://www.secactions.com/five-settle-insider-trading-charges-with-sec/
The case centers on the acquisition of Pharmasset Inc. by Gilead Sciences Inc. Pharmasset is a clinical stage pharmaceutical company based in Princeton, New Jersey. Named as defendants are Robert Spallina, a partner in the law firm of Spallina and Tescher, P.A.; Thomas Palermo, a registered representative in a brokerage firm; Brian Markowitz, a ...
Searching for Pharmasset Inc Hours?
You can just click the links above. The info is collected for you.
